Nevro (NVRO) News Today $5.74 +0.01 (+0.09%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$5.74 0.00 (0.00%) As of 02/21/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Nevro (NYSE:NVRO) and Adynxx (OTCMKTS:ADYX) Critical ComparisonFebruary 22 at 2:29 AM | americanbankingnews.comGlobus Medical price target lowered to $93 from $95 at Wells FargoFebruary 21 at 6:56 PM | markets.businessinsider.comNevro (NYSE:NVRO) Now Covered by Analysts at StockNews.comFebruary 19 at 2:30 AM | americanbankingnews.comNevro (NYSE:NVRO) Earns Hold Rating from Analysts at StockNews.comStockNews.com assumed coverage on shares of Nevro in a report on Tuesday. They issued a "hold" rating for the company.February 18, 2025 | marketbeat.comGlobus Medical's SWOT analysis: stock outlook amid acquisition and FDA warningFebruary 17, 2025 | msn.comNevro Corp's SWOT analysis: acquisition shakes up struggling SCS stockFebruary 17, 2025 | msn.comNevro (NVRO) Projected to Post Earnings on WednesdayFebruary 17, 2025 | americanbankingnews.comARMISTICE CAPITAL, LLC Increases Stake in Nevro CorpFebruary 15, 2025 | gurufocus.comShay Capital LLC Reduces Stake in Nevro Corp: An In-Depth AnalysisFebruary 14, 2025 | gurufocus.comEngaged Capital's Q4 moves include BlackLine, Nevro exits, new stake in Chart IndustriesFebruary 14, 2025 | seekingalpha.comNevro (NVRO) to Release Earnings on WednesdayNevro (NYSE:NVRO) will be releasing earnings after the market closes on Wednesday, February 19, Financial Modeling Prep reports.February 12, 2025 | marketbeat.comJefferies raises Nevro stock rating, boosts price target to $5.85February 10, 2025 | msn.comNevro (NYSE:NVRO) Stock Rating Upgraded by Jefferies Financial GroupJefferies Financial Group raised shares of Nevro from an "underperform" rating to a "hold" rating and raised their target price for the stock from $4.50 to $5.85 in a report on Monday.February 10, 2025 | marketbeat.comNevro upgraded to Hold from Underperform at JefferiesFebruary 8, 2025 | markets.businessinsider.comPiper Sandler Upgrades Nevro (NVRO)February 8, 2025 | msn.comCanaccord Genuity Group Issues Positive Forecast for Nevro (NYSE:NVRO) Stock PriceCanaccord Genuity Group raised their price objective on Nevro from $4.00 to $5.85 and gave the company a "hold" rating in a research note on Friday.February 7, 2025 | marketbeat.comNevro price target raised to $5.85 from $4 at CanaccordFebruary 7, 2025 | markets.businessinsider.comNevro (NYSE:NVRO) Upgraded at Piper SandlerPiper Sandler upgraded shares of Nevro from a "neutral" rating to an "overweight" rating and cut their target price for the stock from $6.00 to $5.85 in a research note on Friday.February 7, 2025 | marketbeat.comPiper Sandler raises Nevro stock to Neutral, cuts target to $5.85February 7, 2025 | msn.comNevro upgraded to Neutral from Underweight at Piper SandlerFebruary 6, 2025 | markets.businessinsider.comGlobus Medical To Acquire Nevro For $250 MlnFebruary 6, 2025 | markets.businessinsider.comGlobus Medical to Acquire Nevro Corp. to Expand Treatment Options for PatientsFebruary 6, 2025 | finance.yahoo.comGlobus acquisition of Nevro ‘fairly low-risk bet,’ says BTIGFebruary 6, 2025 | markets.businessinsider.comGlobus Medical to acquire Nevro for $5.85 per shareFebruary 6, 2025 | msn.comGlobus Medical Announces Acquisition of Nevro CorpFebruary 6, 2025 | tipranks.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Nevro Corp. - NVROFebruary 6, 2025 | prnewswire.comNVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Nevro Corp. Is Fair to ShareholdersFebruary 6, 2025 | businesswire.comGlobus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 MillionFebruary 6, 2025 | quiverquant.comShareholder Alert: Ademi & Fruchter LLP Investigates Whether Nevro Corp. Is Obtaining a Fair Price for Its Public ShareholdersFebruary 6, 2025 | businesswire.comNevro Corp. (NYSE:NVRO) Receives Consensus Rating of "Reduce" from BrokeragesShares of Nevro Corp. (NYSE:NVRO - Get Free Report) have received an average recommendation of "Reduce" from the thirteen analysts that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating and ten have given a hold ratFebruary 6, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 258,521 Shares of Nevro Corp. (NYSE:NVRO)Assenagon Asset Management S.A. trimmed its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 27.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 670,827 shares of the medical equipment provJanuary 23, 2025 | marketbeat.comNevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08January 21, 2025 | prnewswire.comNevro Corp. (NYSE:NVRO) Shares Sold by Barclays PLCBarclays PLC reduced its stake in shares of Nevro Corp. (NYSE:NVRO - Free Report) by 59.0% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 61,496 shares of the medical equipment provider's stock after selling 88,518 shares during the pJanuary 20, 2025 | marketbeat.comCiti Reaffirms Their Hold Rating on Nevro Corp (NVRO)January 17, 2025 | markets.businessinsider.comRBC Capital Sticks to Their Hold Rating for Nevro Corp (NVRO)January 16, 2025 | markets.businessinsider.comNevro Corp: Balancing Short-Term Gains and Long-Term Uncertainties with a Hold RatingJanuary 14, 2025 | markets.businessinsider.comNevro sees Q4 revenue $105M-$106M, consensus $100.08MJanuary 14, 2025 | markets.businessinsider.comNevro sees FY24 revenue ~$408M-$409M, consensus $403.14MJanuary 14, 2025 | markets.businessinsider.comNevro Corp.: Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue ResultsJanuary 13, 2025 | finanznachrichten.deNevro Shares Rise 16% After 4Q, 2024 Revenue GuidanceJanuary 13, 2025 | marketwatch.comNevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue ResultsJanuary 13, 2025 | prnewswire.comNevro Corp. (NYSE:NVRO) Given Average Recommendation of "Reduce" by AnalystsNevro Corp. (NYSE:NVRO - Get Free Report) has earned an average rating of "Reduce" from the thirteen research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell recommendation and ten have assigned a hold recommendation to thJanuary 12, 2025 | marketbeat.comState Street Corp Sells 241,495 Shares of Nevro Corp. (NYSE:NVRO)State Street Corp cut its holdings in Nevro Corp. (NYSE:NVRO - Free Report) by 24.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 752,631 shares of the medical equipment provider's stock after selling 241,495December 30, 2024 | marketbeat.comRBC Capital Remains a Hold on Nevro Corp (NVRO)December 20, 2024 | markets.businessinsider.comTruist Financial Has Lowered Expectations for Nevro (NYSE:NVRO) Stock PriceTruist Financial cut their price target on shares of Nevro from $7.00 to $4.70 and set a "hold" rating on the stock in a report on Wednesday.December 18, 2024 | marketbeat.comNevro Corp. (NYSE:NVRO) Receives Consensus Recommendation of "Reduce" from AnalystsShares of Nevro Corp. (NYSE:NVRO - Get Free Report) have received an average rating of "Reduce" from the fourteen ratings firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation and eleven have assigned a hold recommendationDecember 18, 2024 | marketbeat.comNevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08December 17, 2024 | prnewswire.comNevro Corp (NVRO) Receives a Hold from Wells FargoDecember 11, 2024 | markets.businessinsider.comNevro price target lowered to $5 from $6 at CitiDecember 11, 2024 | markets.businessinsider.comZacks.com featured highlights include Stryve Foods, Nevro, Canoo, MSA Safety and VTEXDecember 11, 2024 | finance.yahoo.com Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address NVRO Media Mentions By Week NVRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVRO News Sentiment▼0.000.60▲Average Medical News Sentiment NVRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVRO Articles This Week▼74▲NVRO Articles Average Week Get Nevro News Delivered to You Automatically Sign up to receive the latest news and ratings for NVRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bioventus News Today AxoGen News Today CeriBell News Today Avanos Medical News Today Iradimed News Today SI-BONE News Today Treace Medical Concepts News Today OrthoPediatrics News Today Delcath Systems News Today ClearPoint Neuro News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVRO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nevro Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nevro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVRO Stock Alerts